AI-generated summary
This review describes photobiomodulation, a non-invasive light-based approach, as a potential treatment for central nervous system disorders. The authors report that human studies showed improvements in cognition, motor symptoms, and emotional distress in neurodegenerative, brain trauma, and psychiatric conditions. They note that outcomes depend on wavelength, dosage, frequency, and individual variability, and call for larger clinical trials.
- Who or what was studied
- Patients with neurodegenerative diseases, brain trauma, and psychiatric disorders
- Limits stated in the abstract
- The abstract does not report the number of studies or participants, and it calls for large-scale trials to validate long-term safety and efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on portlandpress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Cytochrome c oxidase, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.